WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today announced a clinical study of Quell ® Wearable Pain Relief Technology™ in patients with chronic low back pain at the Brigham and Women's Hospital Pain Management Center.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced that Frank McGillin , Senior Vice President and General Manger , Consumer, will participate in a panel discussion on the THE DIGITAL HEALTHCARE REVOLUTION at the Wearable Technology Show in Santa Clara, CA on
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that Synovation Medical Group will conduct an evaluation of Quell ® Wearable Pain Relief Technology™ in fibromyalgia patients. "We have seen both clinical data and positive reviews that suggest that Quell
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) reported today on multiple efforts to increase the availability of Quell ® Wearable Pain Relief Technology™ to veterans who suffer from chronic pain through the Veterans Health Administration .
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that the Company's Quell ® Wearable Pain Relief Technology™ has won the Electronics Retailer Association Moxie Award for the Best Health Show 2016. This Moxie award recognizes the year's best direct response
Omron Leading Local Initiatives WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today reported final regulatory approval in China for DPNCheck ® , a diagnostic test for peripheral neuropathy. DPNCheck is registered as a Class II Medical Device with the China Food and Drug
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that Comprehensive Pain Specialists will offer Quell ® Wearable Pain Relief Technology™ in selected clinic locations. "We are pleased that a growing number of forward-thinking pain management providers are
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced it will be featured as a presenting company at the 18 th Annual Rodman & Renshaw Global Investment Conference , sponsored by H.C. Wainwright & Co., LLC . The conference is being held on September 11-13, 2016 , at
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the State Intellectual Property Office of the People's Republic of China has issued Chinese Patent No. ZL20118055305.7 for the core technology underlying the Company's DPNCheck ® device, which is a
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced the launch of a new website to promote Quell ® , the company's rapidly growing pain relief brand. The new site reflects NeuroMetrix' focus on helping people with chronic pain reclaim their lives.
